Conditioned medium obtained from human amniotic membrane-derived mesenchymal stem cell attenuates heart failure injury in rats

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 429

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-22-11_002

تاریخ نمایه سازی: 20 مهر 1398

Abstract:

Objective(s): Heart failure (HF) is one of the leading causes of death worldwide. Due to beneficial effects of stem cells, paracrine secretion of them has recently been used by researchers. The purpose of this study was to investigate the effects of intravenous injection (IV) of conditioned medium (CM) of human amniotic membrane-derived mesenchymal stem cell (MSC-CM) on HF.Materials and Methods: Male Wistar rats (n=35, 180 g) were randomly divided into five groups: sham, HF, HF+MSC-CM, HF+culture medium and HF+phosphate-buffered saline (PBS). To induce HF, isoproterenol (170 mg/kg/d) was injected subcutaneously for 4 consecutive days. After 28 days, induction of HF was evaluated by echocardiography. A day after echocardiography, 50 μg culture medium/5 ml PBS in HF+culture medium group, 50 μg MSC-CM/5 ml PBS in HF+MSC-CM group and 5 ml PBS in HF+PBS group were injected  two times for 4 successive days. The echocardiography was performed 4 weeks after the last injection of isoproterenol. To evaluate the fibrosis, morphology, and cardiac function, Trichrome Masson’s staining, Hematoxylin and Eosin staining and echocardiography were performed, respectively.Results: CM significantly increased fractional shortening and ejection fraction, and also significantly decreased apoptotic nuclear condensation. Moreover, significant decreased level of fibrosis and increased level of angiogenesis was observed in the treatment group (P<0.05).Conclusion: Our results indicated that IV injection of CM has therapeutic effects on HF by reducing fibrosis and preventing the progression of failure due to its paracrine effects.

Keywords:

Adipose tissue-derived-mesenchymal stem cells , Apoptosis , Conditioned medium , Fibrosis , heart failure

Authors

Solmaz Nasseri Maleki

Physiology Research Center and Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

Nahid Aboutaleb

Physiology Research Center and Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

Donya Nazarinia

Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

Sara Allahverdi Beik

Physiology Research Center and Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Cowie M, Wood D, Coats A, Thompson S, Suresh V, ...
  • Gheorghiade M, Bonow RO. Chronic heart failure in the United ...
  • Bhat P, Tang WW. Biomarkers to Assess and Guide the ...
  • Amani H, Habibey R, Hajmiresmail S, Latifi S, Pazoki-Toroudi H, ...
  • Amani H, Ajami M, Maleki SN, Pazoki-Toroudi H, Daglia M, ...
  • Ajami M, Davoodi SH, Habibey R, Namazi N, Soleimani M, ...
  • Habibey R, Ajami M, Ebrahimi SA, Hesami A, Babakoohi S, ...
  • Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and ...
  • Amani H, Mostafavi E, Arzaghi H, Davaran S, Akbarzadeh A, ...
  • Teerlink JR, Metra M, Filippatos GS, Davison BA, Bartunek J, ...
  • Bartolucci J, Verdugo FJ, González PL, Larrea RE, Abarzua E, ...
  • Halkos ME, Zhao Z-Q, Kerendi F, Wang N-P, Jiang R, ...
  • Patel AN, Silva F, Winters AA. Stem cell therapy for ...
  • Tse HF, Siu CW, Zhu SG, Songyan L, Zhang QY, ...
  • Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. ...
  • Trounson A, McDonald C. Stem cell therapies in clinical trials: ...
  • Gnecchi MJSctm. Cell therapy for heart regeneration: Learning from the ...
  • Arsalan M, Dhein S, Aupperle H, Rastan AJ, Barten MJ, ...
  • Bing W, Pang X, Qu Q, Bai X, Yang W, ...
  • Baglio SR, Pegtel DM, Baldini N. Mesenchymal stem cell secreted ...
  • Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms ...
  • Aboutaleb N, Faezi M, Maleki SN, Nazarinia D, Tousi SMTR, ...
  • Cunningham CJ, Redondo-Castro E, Allan SMJJoCBF, Metabolism. The therapeutic potential ...
  • Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, ...
  • Barile L, Biemmi V, Ciullo A, Torre T, Demerzis S, ...
  • Kervadec A, Bellamy V, El Harane N, Arakélian L, Vanneaux ...
  • Golle L, Gerth HU, Beul K, Heitplatz B, Barth P, ...
  • Faezi M, Maleki SN, Aboutaleb N, Nikougoftar. The membrane mesenchymal ...
  • Liu Y-H, Lu M, Xie Z-Z, Hua F, Xie L, ...
  • Pazoki-Toroudi H, Amani H, Ajami M, Nabavi SF, Braidy N, ...
  • Mehrjerdi FZ, Aboutaleb N, Pazoki-Toroudi H, Soleimani M, Ajami M, ...
  • Pazoki‐Toroudi HR, Ajami M, Habibey R. Pre‐medication and renal pre‐conditioning: ...
  • Habibey R, Pazoki‐Toroudi HJC, Pharmacology E, Physiology. Morphine dependence protects ...
  • Ajami M, Pazoki-Toroudi H, Amani H, Nabavi SF, Braidy N, ...
  • Höglund M. Stem cell transplantation. HemaSphere 2018; 2:159. ...
  • Naderi‐Meshkin H, Bahrami AR, Bidkhori HR, Mirahmadi M, Ahmadiankia N. ...
  • Luger D, Lipinski MJ, Westman PC, Glover DK, Frias JC, ...
  • Kim W-S, Park B-S, Sung J-H. The wound-healing and antioxidant ...
  • Wang CY, Yang HB, Hsu HS, Chen LL, Tsai CC, ...
  • Li Z, Guo J, Chang Q, Zhang A. Paracrine role ...
  • Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, ...
  • نمایش کامل مراجع